Q BIOMED INC. ADVISOR AND MANNIN RESEARCH INC CSO DR SUSAN QUAGGIN ELEQUENTLY DISCUSSES GLAUCOMA AND MAN-01 WITH EYE ON VISION RADIO

Media Alert – Radio and Podcast Interview with Eye on Vision WYPL-FM 89.3 NEW YORK, July 14 2016 — Q BioMed Inc. (OTCQB: QBIO), partner Mannin Research Inc. CSO Dr. Susan Quaggin discusses glaucoma, treatment options, and her novel findings on the relationship between Tie2/TEK signaling, Schelmm’s Canal and glaucoma with Eye on Vision. In […]

Read More

NEW SNN Interview with Q BioMed Inc. CEO Mr. Denis Corin at the Marcum Microcap Conference June 2016

In this video interview, Mr. Corin and SNN host Robert Kraft discuss the following topics: Overview of Q BioMed Inc. Update since our last interview (Click here) Discusses recent news and catalysts New potential FDA approved Drug License Deal What differentiates QBIO from the competition Communicating the stories of projects under development Near-term goals and […]

Read More

Media Alert – Q BioMed Inc Featured in April issue of PharmaVOICE Magazine

Getting Past the “Pharma Bro”; How Smaller Biotechs Continue to Strive for the Well-Being of Patients   New York,  April 5 ,2016  – Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company reports the Company’s CEO  was featured in  an interview in the April issue of PharmaVOICE magazine. PharmaVOICE magazine, reaching more  than 41,000 BPA-qualified life-sciences […]

Read More

StockNewsNow.com Publishes New SNNLive Video Interview With Q BioMed Inc.

LOS ANGELES, CA–(Marketwired – March 24, 2016) –  StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Denis Corin, Chairman and CEO of Q BioMed Inc. (OTCQB: QBIO), a biomedical acceleration and development company, according to the Company’s website (see here: www.QBioMed.com). The video interview was recorded on Monday, February 22nd, […]

Read More

President of Q BioMed Inc. Expands on Corporate Update in Q&A

Denis Corin Discusses Mannin Research Inc’s Leading Glaucoma Drug Candidate MAN-01   POINT ROBERTS, WA–(Marketwired – March 21, 2016) –  Investorideas.com, a digital global news source covering leading sectors including medical technology and biotech stocks releases a recent interview with Mr. Denis Corin, President of Q BioMed Inc. (OTCQB: QBIO). Denis expands on the recent corporate […]

Read More

Vision Monday – Q BioMed Inc. and Mannin Research Inc. Sign Definitive License Agreement

Latest News Q BioMed Inc. and Mannin Research Inc. Sign Definitive License Agreement  By Staff Friday, November 6, 2015 12:18 AM NEW YORK—Q BioMed Inc. (OTC Pink: QBIO), a biotechnology acceleration company has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc., a biotechnology company leading the […]

Read More

GEN News – Q BioMed Licenses Mannin Platform for Vascular Drugs

GEN News Highlights Oct 30, 2015 Q BioMed Licenses Mannin Platform for Vascular Drugs Q BioMed said today it agreed to exclusively license—with an option to acquire—platform technology assets of Mannin Research, the developer of a new class of vascular therapeutics. Mannin’s primary focus is developing a first-in-class therapeutic eye-drop for glaucoma in adults and […]

Read More
Social media & sharing icons powered by UltimatelySocial